Free tool
FAERS Monitor: Mesnex
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019884 or its brand name (Mesnex, Mesna). Reports on generic versions are filed under their own applications.
Reports
8,485
Serious
8,228
97% of reports
Hospitalization
4,013
Death reported
1,763
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- febrile neutropenia1,311
- pyrexia713
- off label use665
- neutropenia587
- anaemia411
- thrombocytopenia402
- vomiting387
- nausea381
- pancytopenia373
- sepsis367
- mucosal inflammation347
- diarrhoea346
- pneumonia297
- disease progression284
- death261
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 147 |
| 2005 | 115 |
| 2006 | 119 |
| 2007 | 87 |
| 2008 | 139 |
| 2009 | 137 |
| 2010 | 190 |
| 2011 | 368 |
| 2012 | 338 |
| 2013 | 249 |
| 2014 | 244 |
| 2015 | 342 |
| 2016 | 337 |
| 2017 | 311 |
| 2018 | 567 |
| 2019 | 607 |
| 2020 | 640 |
| 2021 | 722 |
| 2022 | 623 |
| 2023 | 589 |
| 2024 | 655 |
| 2025 | 608 |
| 2026 | 351 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,045,674 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| febrile neutropeniaSignal | 1,311 | 50.0 | 47.5 | 61,803 |
| mucosal inflammationSignal | 347 | 33.3 | 30.0 | 10,703 |
| pancytopeniaSignal | 373 | 16.6 | 15.1 | 5,449 |
| neutropeniaSignal | 587 | 10.7 | 9.9 | 5,189 |
| thrombocytopeniaSignal | 402 | 8.9 | 8.1 | 2,832 |
| sepsisSignal | 367 | 8.2 | 7.4 | 2,310 |
| disease progressionSignal | 284 | 6.0 | 5.3 | 1,172 |
| anaemiaSignal | 411 | 5.4 | 4.9 | 1,460 |
| pyrexiaSignal | 713 | 5.1 | 4.8 | 2,392 |
| pneumoniaSignal | 297 | 2.3 | 2.0 | 214 |
| vomitingSignal | 387 | 2.0 | 1.9 | 209 |
| off label use | 665 | 1.9 | 1.8 | 286 |
| diarrhoea | 346 | 1.3 | 1.2 | 29 |
| nausea | 381 | 1.2 | 1.1 | 12 |
| death | 261 | 0.8 | 0.7 | 22 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.